©The Author(s) 2021.
World J Orthop. Jun 18, 2021; 12(6): 395-402
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.395
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.395
Table 1 Demographic factors for patients included in this study
| No. of IIM patients | No. of control patients | P value | |
| Total number of patients | 545 | 545 | |
| Female patients | 74.90% | 74.90% | 1.000 |
| Age (yr) | |||
| ≤ 64 | 24.4% | 23.6% | |
| 65-69 | 25.0% | 24.1% | |
| 70-74 | 19.1% | 19.7% | 0.993 |
| 75-79 | 17.1% | 18.1% | |
| 80-84 | 11.4% | 11.2% | |
| ≥ 85 | 3.1% | 3.4% | |
| Region | |||
| Midwest | 23.1% | 26.8% | |
| Northeast | 18.5% | 21.5% | 0.1851 |
| South | 41.3% | 36.9% | |
| West | 17.1% | 14.9% |
- Citation: Rosas S, Schallmo M, Gowd AK, Akelman MR, Luo TD, Emory CL, Plate JF. Dermatomyositis and polymyositis in total hip arthroplasty. World J Orthop 2021; 12(6): 395-402
- URL: https://www.wjgnet.com/2218-5836/full/v12/i6/395.htm
- DOI: https://dx.doi.org/10.5312/wjo.v12.i6.395